Table 1—

Patients' characteristics and baseline ventilator settings at the beginning of the experimental trial

Patient no.Age yrspHPa,CO2 mmHgPa,O2/FI,O2FEV1 % predFEV1/FVC %PS cmH2OPEEPext cmH2OInitial pressurisation rate cmH2O·s−1
1747.3194.30264.0021.0018.0014.002.0080.00
2657.2882.70258.0043.0033.0015.004.00120.00
3837.3277.30190.0018.0025.0014.002.0060.00
4567.3460.70275.0022.0019.0018.004.00120.00
5747.3063.60156.00nana16.004.0060.00
6787.2571.50128.0033.0022.0012.004.0060.00
7677.3356.70249.00nana15.002.0080.00
8687.2971.70281.00nana18.004.00100.00
9807.2193.50222.0028.0037.0014.005.0058.00
10777.16104.20146.0024.0041.0022.006.0060.00
11817.3357.2189.0017.0062.0012.002.0080.00
12627.3283.00219.0013.0019.0013.003.0030.00
13717.3481.00237.00nana14.004.00120.00
14707.3253.30243.0042.0044.0014.004.0080.00
15617.2969.5240.0015.0021.0018.004.0050.00
Mean±sd7±7.97.32±0.0168.8±14226±22.521.8±1436.5±20.414.2±23.4±177.5±37
  • Arterial blood gases were taken at the time of the episode of acute respiratory failure, necessitating noninvasive ventilation

  • Pa,CO2: partial pressure of arterial carbon dioxide oxygen

  • Pa,O2: partial pressure of arterial oxygen

  • FI,O2: fractional concentration of oxygen

  • FEV1: forced expiratory volume in one second

  • % pred: % predicted

  • FVC: forced vital capacity

  • PS: pressure support level

  • PEEPext: external positive end-expiratory pressure

  • na: not available

  • kPa=mmHg×0.133